What is Datavant?
Headquartered in San Francisco, Datavant operates at the intersection of medical research and data science. The company provides a robust software ecosystem designed to link and share healthcare data while maintaining stringent safety and compliance standards. By bridging the gap between siloed health systems, Datavant enables researchers and providers to derive actionable insights from fragmented datasets, ultimately accelerating the pace of medical innovation and improving patient outcomes. Its market position is defined by its ability to solve the complex regulatory and technical challenges inherent in large-scale health data integration.
How much funding has Datavant raised?
Datavant has raised a total of $121M across 3 funding rounds:
Series A
$40.5M
Other Financing Round
$40.5M
Series B
$40M
Series A (2018): $40.5M with participation from Roivant Sciences
Other Financing Round (2018): $40.5M led by Roivant Sciences
Series B (2020): $40M supported by Cigna Ventures, Transformation Capital Group Ltd, Flex Capital, Roivant Sciences Ltd., and Johnson & Johnson Innovation – JJDC, Inc.
Key Investors in Datavant
Roivant Sciences
A tech-enabled healthcare organization focused on developing late-stage drug candidates and deploying innovative medical technologies.
Flex Capital
A private equity firm specializing in growth-stage software and technology companies with scalable business models.
Cigna Ventures
The corporate venture arm of Cigna, focused on investing in innovative healthcare startups that improve patient health and affordability.
What's next for Datavant?
With the support of its latest capital injection, Datavant is well-positioned to expand its enterprise footprint and deepen its integration capabilities within the global healthcare ecosystem. The company is expected to prioritize the scaling of its data-sharing infrastructure, focusing on enhancing security protocols and broadening its network of institutional partners. As the demand for high-fidelity, longitudinal health data continues to rise, Datavant's strategic roadmap likely involves further investment in machine learning-driven analytics and the expansion of its footprint into new international markets, ensuring it remains the primary conduit for secure medical data exchange.
See full Datavant company page
